Literature DB >> 20659098

Long-term outcomes of liver transplantation in type 1 Gaucher disease.

R M Ayto1, D A Hughes, P Jeevaratnam, K Rolles, A K Burroughs, P K Mistry, A B Mehta, G M Pastores.   

Abstract

Gaucher disease (GD) is the most prevalent lysosomal storage disorder. Enzyme replacement therapy (ERT) has demonstrable efficacy in reversing clinical and pathological manifestations of GD. We report four patients with GD and severe hepatic impairment who were successfully treated by orthotopic liver transplantation. Liver failure resulted from GD in two patients and due to a comorbidity in two others (HCV and autoimmune chronic active hepatitis). Following successful liver transplantation, patients received long-term ERT. Liver transplantation is a life-saving treatment for end-stage liver disease in patients with Gaucher disease. All four patients have had excellent outcomes from liver transplantation for up to 10 years postprocedure with no evidence of Gaucher-related pathology in the graft.

Entities:  

Mesh:

Year:  2010        PMID: 20659098     DOI: 10.1111/j.1600-6143.2010.03168.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Therapeutic approaches for lysosomal storage diseases.

Authors:  Gregory M Pastores
Journal:  Ther Adv Endocrinol Metab       Date:  2010-08       Impact factor: 3.565

Review 2.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

3.  Clinical variability in neurohepatic syndrome due to combined mitochondrial DNA depletion and Gaucher disease.

Authors:  Julie Harvengt; Catherine Wanty; Boel De Paepe; Christine Sempoux; Nicole Revencu; Joél Smet; Rudy Van Coster; Willy Lissens; Sara Seneca; Laurent Weekers; Etienne Sokal; François-Guillaume Debray
Journal:  Mol Genet Metab Rep       Date:  2014-05-10

4.  Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease.

Authors:  Kunal Adhyaru; Sherna Menezes; Pramod K Mistry; Aabha Nagral
Journal:  Cureus       Date:  2022-04-08

Review 5.  Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.

Authors:  Mahsa Ghasemzad; Mahdieh Hashemi; Zohre Miri Lavasani; Nikoo Hossein-Khannazer; Haleh Bakhshandeh; Roberto Gramignoli; Hani Keshavarz Alikhani; Mustapha Najimi; Saman Nikeghbalian; Massoud Vosough
Journal:  Bioengineering (Basel)       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.